Chicago, IL – March 6, 2025 – Stocks in this week’s article are — Taiwan Semiconductor Manufacturing Company Ltd. TSM, Tapestry, Inc. TPR, ABM Industries ABM, Vertiv Holdings Co. VRT and ResMed Inc. RMD.
Wall Street has been caught in a vicious circle of woes, led by recent tariff escalations and a slowdown in the economy. The U.S. stocks erased all the gains made post-election, and the S&P 500 is now at its lowest level since November when Trump won the Presidential election.
Amid such conditions, investors are in search of safe and consistent income, and dividend investing seems to be a good strategy. Dividends are major sources of consistent income for investors. However, they do not offer dramatic price appreciation. These stocks tend to outperform in a choppy market and can reduce the volatility of a portfolio.
In fact, stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation, as opposed to simple dividend-paying stocks or those with high yields. We have selected five dividend growth stocks — Taiwan Semiconductor Manufacturing Company Ltd., Tapestry, Inc., ABM Industries, Vertiv Holdings Co. and ResMed Inc. — which could be solid choices amid market volatility.
Stocks that have a strong history of dividend growth belong to mature companies less susceptible to large swings in the market and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.
These stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. A history of strong dividend growth indicates that a dividend increase is likely in the future.
Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.
These few criteria narrowed down the universe from more than 7,700 stocks to just 11.
Here are five of the 11 stocks that fit the bill:
Taiwan-based Taiwan Semiconductor is the world's largest dedicated integrated circuit foundry. The company has seen a positive earnings estimate revision of a penny over the past 30 days for this year and has an estimated earnings growth rate of 30.7%.
TSM currently has a Zacks Rank #2 and a Growth Score of B. You can see the complete list of today’s Zacks #1 Rank stocks here.
New York-based Tapestry, which was formerly known as Coach, is the designer and marketer of fine accessories and gifts for women and men in the United States and internationally. The stock saw a solid earnings estimate revision of 28 cents over the past 30 days for the fiscal year (ending June 2025) and has an estimated earnings growth rate of 14.4%.
Tapestry has a Zacks Rank #2 and a Growth Score of A at present.
New York-based ABM Industries is a provider of integrated facility solutions in the United States and internationally. The company’s offerings include janitorial, energy, facilities engineering, electrical and lighting, landscape and turf, HVAC and mechanical, and mission-critical and parking solutions. ABM Industries has an estimated earnings growth rate of 3.9% for the fiscal year (ending October 2025) and delivered an average earnings surprise of 11.56% for the past four quarters.
ABM Industries currently has a Zacks Rank #2 and a Growth Score of B.
Ohio-based Vertiv Holdings provides digital infrastructure and continuity solutions. It offers hardware, software, analytics and ongoing services. The company saw a positive earnings estimate revision of a penny over the past month for this year and has an estimated earnings growth rate of 25.9%.
Vertiv Holdings has a Zacks Rank #2 and a Growth Score of A at present.
California-based ResMed holds a major position as a designer, manufacturer and distributor of generators, masks and related accessories for the treatment of sleep-disordered breathing and other respiratory disorders worldwide. The stock saw a positive earnings estimate revision of 4 cents over the past 30 days for the fiscal year (ending June 2025) and has an expected earnings growth rate of 22.7%.
ResMed currently has a Zacks Rank #2 and a Growth Score of B.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2425857/5-best-dividend-growth-stocks-to-buy-amid-trade-war-fears
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ResMed Inc. (RMD) : Free Stock Analysis Report
ABM Industries Incorporated (ABM) : Free Stock Analysis Report
Taiwan Semiconductor Manufacturing Company Ltd. (TSM) : Free Stock Analysis Report
Tapestry, Inc. (TPR) : Free Stock Analysis Report
Vertiv Holdings Co. (VRT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.